Grünenthal is a global leader in pain management and related diseases. We are a science-based, privately-owned pharmaceutical company headquartered in Germany and with presence in the US, Latin America and Europe. Leveraging external and internal research and knowledge, we have a long track record of bringing innovative treatments to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We focus all our activities and efforts on moving towards our vision of a world free of pain. You can find out more about Grünenthal at https://www.grunenthal.com/.